1. 2022-RA-459-ESGO UPLIFT (ENGOT-ov67/GOG-3048) a registrational trial of Upifitamab Rilsodotin (XMT-1536; UpRi), a NaPi2b-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer. (20th October 2022) Authors: Concin, Nicole; Monk, Bradley J; Mirza, Mansoor Raza; Coleman, Robert L; Ray-Coquard, Isabelle; Pothuri, Bhavana; Baurain, Jean-Francois; Alejandro Perez-Fidalgo, J; Cibula, David; Saverse, Antonella; Banerjee, Susana; Madry, Radek; Marth, Christian; Putiri, Emily; Barrett, Jamie; DeMars, Leslie;... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EP017/#425 Comparison of NAPI2B expression from paired tissue samples in a clinical study of upifitamab rilsodotin (UPRI; XMT-1536) supports a strategy of testing in archive material. (4th December 2022) Authors: Richardson, Debra; Barve, Minal; Saltos, Andreas; Papadopoulos, Kyriakos; Hays, John; Tolcher, Anthony; Ellard, Susan; Doroshow, Deborah; Mitchell, Paul; Zarwan, Corrine; Werner, Theresa; Anderson, Charles; Spira, Alex; Mileshkin, Linda; Bradshaw, Chelsea; Demars, Leslie; Mosher, Rebecca; Hamilto... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP341/#510 Exploratory results of a phase IB trial of paclitaxel and carboplatin + galunisertib in patients with uterine and ovarian carcinosarcoma. (4th December 2022) Authors: Washington, Christina; Gunderson-Jackson, Camille; Walker, Joan; Mannel, Robert; Holman, Laura; Richardson, Debra; Neelakantan, Deepika; Cohoon, Andrew; Bhattacharya, Resham; Ding, Kai; Dwivedi, Shailendra; Gatalica, Zoran; Qian, Liangyue; Moxley, Katherine; Landrum, Lisa; Rowland, Michelle; Moor... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. O012/#352 Atezolizumab and bevacizumab in recurrent endometrial cancer: a phase II, multi institutional trial. (4th December 2022) Authors: Fuh, Katherine; Richardson, Debra; Arend, Rebecca; Mccourt, Carolyn; Hagemann, Andrea; Liang, Margaret; Holman, Laura; Washington, Christina; Walker, Joan; Mannel, Robert; Youn, Grace; Mutch, David; Huh, Warner; Cohoon, Andrew; Iii, Charles Leath; Powell, Matthew; Gunderson-Jackson, Camille; Moor... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: an NRG Oncology Group study. Issue 5 (28th February 2020) Authors: Chase, Dana; Huang, Helen Q; Monk, Bradley J; Ramondetta, Lois Michelle; Penson, Richard T; Gil, Karen; Landrum, Lisa M; Leitao, Mario; Oaknin, Ana; Huh, Warner K; Pulaski, Heather L; Robison, Katina; Guntupalli, Saketh R; Richardson, Debra; Salani, Ritu; Sill, Michael W; Wenzel, Lari B; Tewari, ... Journal: International journal of gynecological cancer Issue: Volume 30:Issue 5(2020) Page Start: 596 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. TP036/#426 Uplift (ENGOT-OV67/GOG-3048) a pivotal cohort of the XMT-1536–1 trial of upifitamab rilsodotin (XMT-1536; UPRI), a NAPI2B-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer. (4th December 2022) Authors: Richardson, Debra; Perez Fidalgo, Jose Alejandro; Gonzalez-Martin, Antonio; Oaknin, Ana; Hamilton, Erika; Hays, John; Pothuri, Bhavana; Papadopoulos, Kyriakos; Taylor, Sara; Huang, Marilyn; Lee, Yeh-Chen; Krivak, Thomas; Moreno-Garcia, Victor; Calvo, Emiliano; Randall, Leslie; Starks, David; Ross... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. TP037/#453 Up-next (GOG-3049/ENGOT-OV71-NSGO-CTU): a study of upifitamab rilsodotin (UPRI), a NaPi2b -directed antibody drug conjugate (ADC) in platinum-sensitive recurrent ovarian cancer. (4th December 2022) Authors: Richardson, Debra; Harter, Philipp; O'Malley, David; Gonzalez-Martin, Antonio; Herzog, Thomas; Rogalski, Caroline; Burger, Robert; Mirza, Mansoor Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗